Febuliv 40 Tablet contains Febuxostat 40mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat is a xanthine oxidase inhibitor that works by reducing the production of uric acid in the body, thereby preventing the formation of urate crystals which cause joint inflammation and pain associated with gout. This medication is typically prescribed to individuals who have not responded well to other urate-lowering therapies or who have contraindications to those treatments. Febuliv 40 is effective in lowering serum uric acid levels, helping to reduce the frequency of gout attacks and improve overall joint health. It is important to take this tablet exactly as prescribed by a healthcare professional, usually once daily, with or without food. Patients should inform their doctor about any existing medical conditions, allergies, or other medications they are taking to avoid potential interactions or side effects. Common side effects may include nausea, rash, or liver enzyme abnormalities, and any unusual symptoms should be reported promptly. Regular monitoring of uric acid levels and liver function tests is recommended during treatment to ensure safety and efficacy. Febuliv 40 Tablet offers a targeted approach to managing gout and maintaining quality of life for affected individuals.